Ace Therapeutics, a leading IBD research service company, revealed its novel IBD animal models, created to bridge the complex challenges of IBD drug discovery and innovative therapy development. The news is a significant milestone in bridging the gap between preclinical research and clinical success, as part of global efforts towards advancing precision medicine and regulatory compliance in...
Ace Therapeutics, a leading preclinical research organization, unveils its specialized nephrology-focused preclinical solutions to accelerate kidney disease drug development. With a comprehensive suite of validated models and cutting-edge technologies, Ace Therapeutics empowers researchers and biopharma companies to overcome challenges in renal drug discovery and translation.
Kidney disease...
Ace Therapeutics announced the launch of its custom ocular modeling services, designed to accelerate advancements in ophthalmology research and enhance the discovery of therapeutic interventions. This groundbreaking service provides researchers with tailored models that closely mimic human ocular conditions, enabling more reliable results in preclinical studies.
As ophthalmological...
Ace Therapeutics, a preclinical CRO in psychiatry dedicated to offering comprehensive one-stop services, released the expansion of its research capabilities in the area of depression through the introduction of comprehensive depression-related behavior tests in its preclinical investigation processes. This integral development aims to enhance the understanding of depressive disorders and...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek